FDA Investigator Danny D Horner

Danny D Horner has inspections in 1 countries as of 21 Sep 2023. Danny D Horner has collaborated with a combinined 3544 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
300
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams, Adam C Hipko, Adrian Rodriguez, Akbar J Zaidi, Alan A Rivera, Alanna Lmussawwir Bias, Alcee M Tavarez, Amanda J White, Andrea A Branche, Andrew J Lang, Anh M Lac, Arie R Dyk, Ashley N Williams, Barbara J Rincon, Benjamin K Kingsley, Betsy C Galliher, Bing Lin, Blondell W Johnson, Brackens Harris, Brandon K Barbee, Brenda G Stewart Munoz, Brent Sexton, Brook Shea, Camille D Brown, Carol A Declouette Wilburn, Casey L Hamblin, Cathleen A Castellaw, Chad J Whitwell, Charles B Steinmiller, Charles D Brown, Chmura, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher K Gibbs, Christopher L Jacobs, Cindy J Jeffrey, Coleen L Manoy, Connie L Hannon Rabel, Constance M Dobbins, Crystal S Harris, Crystal S Harris Smith, Cymbre Weatherly, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Dana M Lewis, Dana S Jernigan, Daniel J Lahar, Daniel S Fam, Danielle Lyke, Danny D Homer, Daphne A Videau, Darla J Christopher, David M Beltran, Davis Tx, Dawn P Hall, Decarlos A Gomez, Denise Connelly, Deniza Karacic, Dirk L Lincoln, Ed Gonzalez Vazquez, Edmiston, Edward D Edmiston, Elisa M Fleming, Elkins, Ellen J Tave, Elvia J Cervantes, Erick G Marchan, Ernest Serna, III, Fernando C Martinez, Floyd D Herd, Frans E Mercado, Gatica, George D Jackson, Gery M Duparc, Gilbert Valdez Eps, II, Gilbreath, Glasgow, Grant, Grant L Davis, Gregory A Holt, H Ljamilla Selby, Hala L Selby, Haley L Coleman, Harperd, Hung V Le, Hurst, Iris C Macinnes, Jacob W Reynolds, James C Warren, James H Robinson, Jamie M Bumpas, Jane M Broussard, Janet B Abt, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jennifer Owens Dowdy, Jeremy L Stukes, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John T Chapman, Johnson, Jonaida Estevez Martinez, Jonathan A Womack, Jonathan M Mcbride, Joshua A Moore, Joy L Ramsey, Juan D Lopez, K Gonzlez, Kamara Tx, Kanika B Topiwala, Karen A Coleman, Kari M Johansen, Karlton T Watson, Kathleen Chmura Shaffer, Kayla R Deatherage, Keith A Harvey, Kelly D Sheppard, Kenitra D Hewitt, Khunnathee Stoner, Kia L Copeland, Kristin N Longfellow, Kunapuli T Madhusudhan, L Grant, Lauren E Skokan, Lauren R Brady, Leighton K Ngai, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Liza L Quiles, Lloyd D Payne, Loan T Tran, Lorie S Hannappel, Lourdes R Genera, Lowell R Oates, Lynnette I Riggio, Maira P Brading, Marc R Dickens, Margaret M Annes, Martha S Baldwin, Martinez, Massoud Motamed, Matthew S Mccollough, Michael L Jones, Monica J Wilkins, Monique Rac Lester, Monique S Frazier, Msdap Gonzlezk, Osama A Khatib, Paul E Frazier, Paul Perdue (NMI), Jr, Pauline N Logan, Payne, Perla M Castillo, Philip M Steele, PhD, Phillip J Sample, Pitman, Quynh Anh H Tran, Rebecca C O Bryan, Rebecca C O'bryan, Rendall E Barfoot, Rene R Ramirez, Renee Johnson, RS, Rhonda L Dash, Rian L Pope, Robert M Tillman, Robert P Neligan, Robert T Harris, Robert T Lorenz, Rodriguez, Roy Baby, Saijal P Naik, Samuel A Hamblin, Samuel R Carter, Sandy J Ziegler, Sarah L Fredric, Scott K Zika, Scott R Nichols, PhD, Scott T Ballard, Sean M Cheney, Selene T Torres, Shannon A Lowe, Shelby N Marler, Sherrie L Krolczyk, Staci G Mcallister, State Agency, Stephen D Brown, Steven L Strom, Storm Vancuso, Susan Djurkovic, Tamera H Hunt, Tamera H Lueckemeyer, Tara A Gray, Timothy B Webb, Timothy J Herrman, Toby Vern H Hill, Tracy J Washington, Travis M Beard, Travis S Brown, Tricia S Martinez, Trina K Vick, Ve Garcia, Vivian Garcia, Yaw O Osei, Young M Yoon, Youngjd, Zerita White, Zumera B Ajani

Danny D Horner's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Eagle Diagnostics, Inc - Form 483, 2002-04-16
December, 2003 EIR International Flavors & Fragrances, Inc - EIR, 2003-12-30
April, 2002 EIR Eagle Diagnostics, Inc - EIR, 2002-04-16
February, 2008 FDA 483 Colgin Inc - Form 483, 2008-02-06
January, 2002 EIR CARGILL INCORPORATED - EIR, 2002-01-09
October, 2005 FDA 483 Seecor, Inc - Form 483, 2005-10-28
February, 2003 FDA 483 Robert Thoni - Form 483, 2003-02-05
June, 2002 EIR CARGILL INCORPORATED - EIR, 2002-06-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more